New practice guidelines issued by the Endocrine Society provide information about osteoporosis medication options and answer questions women may have.

A medication for osteoporosis (thinning bones), certain autoimmune diseases, and suppression of transplant rejection could reduce hair loss (androgenetic alopecia) in both men and women, according to a new study.

In some cases, the risks of these osteoporosis medications indicate that stopping them for a while is a good idea.

If you have osteoporosis, you may be tempted to skip bisphosphonates because you fear the side effects.

Fragility fractures affect up to one-half of women and one-third of men over age 50, but there are steps you can take to help prevent them.

Getting more bone-building calcium by taking supplements seems like it should be a good thing. But some doctors aren’t so sure.

Low testosterone in men—or “low T”—can be caused by certain medical conditions or medications. But findings from several recent studies may cause doctors to be cautious about who should be treated.

Medications approved for treating osteoporosis fall into the following general categories: bisphosphonates, selective estrogen receptor modulators, hormone and hormone-like preparations, monoclonal antibodies and anabolic agents.